Cargando…

Exploration of the total-body PET/CT reconstruction protocol with ultra-low (18)F-FDG activity over a wide range of patient body mass indices

PURPOSE: The purpose of this study was to investigate the image quality and diagnostic performance of different reconstructions over a wide range of patient body mass indices (BMIs) obtained by total-body PET/CT with ultra-low (18)F-FDG activity (0.37 MBq/kg). METHODS: A total of 63 patients who und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sui, Xiuli, Tan, Hui, Yu, Haojun, Xiao, Jie, Qi, Chi, Cao, Yanyan, Chen, Shuguang, Zhang, Yiqiu, Hu, Pengcheng, Shi, Hongcheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894532/ https://www.ncbi.nlm.nih.gov/pubmed/35239037 http://dx.doi.org/10.1186/s40658-022-00445-3

Ejemplares similares

Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity
por: Hu, Yan, et al.
Publicado: (2022)

Different hydration protocols for the quantification of healthy tissue uptake of half-dose (18)F-FDG total-body positron emission tomography–computed tomography: a prospective study
por: Cao, Yanyan, et al.
Publicado: (2023)

Ultra-low-dose CT reconstructed with the artificial intelligence iterative reconstruction algorithm (AIIR) in (18)F-FDG total-body PET/CT examination: a preliminary study
por: Hu, Yan, et al.
Publicado: (2023)

A personal acquisition time regimen of (68)Ga-DOTATATE total-body PET/CT in patients with neuroendocrine tumor (NET): a feasibility study
por: Xiao, Jie, et al.
Publicado: (2022)

Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement?
por: Hu, Pengcheng, et al.
Publicado: (2021)

Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose (18)F-fluorodeoxyglucose in oncology patients
por: He, Yibo, et al.
Publicado: (2022)

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast (18)F-FDG PET/MRI compared to (18)F-FDG PET/CT and CT
por: Kirchner, Julian, et al.
Publicado: (2017)

Performance characteristics of the digital uMI550 PET/CT system according to the NEMA NU2-2018 standard
por: Chen, Shuguang, et al.
Publicado: (2020)

Added value of regional (18)F-FDG PET/MRI-assisted whole-body (18)F-FDG PET/CT in malignant ascites with unknown primary origin
por: Fu, Yiru, et al.
Publicado: (2023)

PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)

Comparison of the Diagnostic Value of MRI and Whole Body (18)F-FDG PET/CT in Diagnosis of Spondylodiscitis
por: Altini, Corinna, et al.
Publicado: (2020)

(18)F-FDG gallbladder uptake: observation from a total-body PET/CT scanner
por: Calabro’, Anna, et al.
Publicado: (2023)

(18)F-FDG PET/CT and Whole-Body Bone Scan Findings in Gorlin–Goltz Syndrome
por: Cheon, Miju, et al.
Publicado: (2023)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

Assessment of pancreatic colloid carcinoma using (18)F-FDG PET/CT compared with MRI and enhanced CT
por: Jiang, Lei, et al.
Publicado: (2018)

Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma
por: Zhou, Jun, et al.
Publicado: (2017)

Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT
por: Nguyen, Nghi C, et al.
Publicado: (2007)

Whole-Body [(18)F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease
por: Fröhlich, Matthias, et al.
Publicado: (2021)

Real-world assessment of the clinical utility of whole body (18)F-FDG PET/CT in the diagnosis of infection
por: Medvedeva, Natalia, et al.
Publicado: (2022)

A proper protocol for routine (18)F-FDG uEXPLORER total-body PET/CT scans
por: Hu, Huiran, et al.
Publicado: (2023)

Correction: Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma
por: Zhou, Jun, et al.
Publicado: (2019)

Estimation of radiation dose to patients from (18)FDG whole body PET/CT investigations using dynamic PET scan protocol
por: Kaushik, Aruna, et al.
Publicado: (2015)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma
por: Westerland, Olwen, et al.
Publicado: (2021)

Dynamic Total-Body PET/CT Imaging Reveals Kinetic Distribution of (68)Ga-DOTATATE in Normal Organs
por: Yin, Hongyan, et al.
Publicado: (2023)

Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis
por: Zhang, Cici, et al.
Publicado: (2023)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients
por: Dyrberg, Eva, et al.
Publicado: (2017)

Can we save our resources with half-body-18F-FDG-PET-CT rather than whole-body, in the management of head & neck cancers?
por: Sonoda, LI, et al.
Publicado: (2014)

Staging of Primary Abdominal Lymphomas: Comparison of Whole-Body MRI with Diffusion-Weighted Imaging and (18)F-FDG-PET/CT
por: Stecco, Alessandro, et al.
Publicado: (2015)

Whole-body MRI versus (18)F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis
por: Wang, Danyang, et al.
Publicado: (2018)

Radiobiological risks in terms of effective dose and organ dose from (18)F-FDG whole-body PET/CT procedures
por: Alameen, Suhaib, et al.
Publicado: (2021)

Diagnostic Significance of 18F-FDG PET/CT Imaging Coupled with Magnetic Resonance Imaging of the Entire Body for Bone Metastases
por: Guo, Huimin, et al.
Publicado: (2022)

Variations induced by body weight and background lesion normalization in standardized uptake value estimated by F18-FDG PET/CT
por: Badawe, Eman M., et al.
Publicado: (2022)

Optimal clinical protocols for total-body 18F-FDG PET/CT examination under different activity administration plans
por: Huang, Yanchao, et al.
Publicado: (2023)

Prognostic value of whole-body dynamic (18)F-FDG PET/CT Patlak in diffuse large B-cell lymphoma
por: Yin, Jiankang, et al.
Publicado: (2023)

Body distribution of (11)C-methionine and (18)FDG in rat measured by microPET
por: Štolc, Svorad, et al.
Publicado: (2011)

A whole-body FDG-PET/CT Dataset with manually annotated Tumor Lesions
por: Gatidis, Sergios, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_96t6rcvf17nhaui5pfde0fq91t